RCS - Zotefoams PLC - High-performance foam in medical facility doors

ZotefoamsAnnouncement

27/04/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230427:nRSa6037Xa&default-theme=true

RNS Number : 6037X  Zotefoams PLC  27 April 2023

27 April 2023

Zotefoams plc

("Zotefoams" or "Group")

 

Agreement to supply high-performance foam for use in medical facility doors

Zotefoams, a world leader in cellular materials technology, is pleased to
announce an agreement with Kennon Products (Wyoming, USA) to supply ZOTEK(®)
F high-performance foam for use in Kennon's newest ligature-resistant patient
safety door, broadening the scope of application for this material. So-called
breakaway doors are used in medical facilities to protect vulnerable patients
from self-harm while affording privacy.

Produced exclusively by Zotefoams and manufactured from PVDF (polyvinylidene
fluoride), ZOTEK F is best-known as a disruptive material that has enabled
airframe manufacturers and airlines to reduce carbon consumption by shedding
significant weight from aircraft interiors. Equally important are the safety
credentials of the material: PVDF is inherently inert, and Zotefoams'
proprietary method of foam manufacture does not affect that essential purity.
Accordingly, ZOTEK F achieves the highest ratings for its Fire, Smoke and
Toxicity (FST) properties and also exhibits excellent resistance to mould and
bacteria growth.

Safety is the foremost consideration in the design of the Kennon Door 2.0. The
softness of ZOTEK F and its light weight combine with breakaway magnetic
hinges to save lives, as do its resistance to flame and - in the event of
ignition - low smoke output. The durable design of the door also enhances the
look of any facility.

Kennon achieved its primary objective, that of developing a door that achieves
the USA's new National Fire Protection Association NFPA-286 certification,
which is required for facility operators wishing to meet certain fire
prevention guidelines.

"The unique properties of ZOTEK F foam are a key reason for our anti-ligature
doors meeting the NFPA-286 standard," said Kennon CEO, Joe Wright.  "Our
partnership with Zotefoams has been a mutual success and together we're
helping to save lives in behavioural health hospitals."

David Stirling, Zotefoams Group CEO, commented, "We were pleased to work
closely with Kennon on this project, selecting and testing various ZOTEK F
materials, while providing support and insight based on our previous
experience of aviation applications and flame testing.

"This application has produced another 'first' for ZOTEK F and demonstrates
the potential of the material to deliver benefits well beyond its current core
markets of aviation and aerospace."

* ENDS *

 

 

Enquiries:

 

                                       +44 (0) 208 664 1600

 Zotefoams plc
 David Stirling, Group CEO

 Gary McGrath, Group CFO

 IFC Advisory (Financial PR & IR)      +44 (0) 203 934 6630
 Graham Herring

 Tim Metcalfe

 Zach Cohen

 

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology
delivering optimal material solutions for the benefit of society. Utilising a
variety of unique manufacturing processes, including environmentally friendly
nitrogen expansion for lightweight AZOTE(®) polyolefin and ZOTEK(®)
high-performance foams, Zotefoams sells to diverse markets worldwide.
Zotefoams uses its own cellular materials to manufacture T-FIT(®) advanced
insulation for demanding industrial markets. Zotefoams also owns and licenses
patented microcellular foam technology to reduce plastic use in extrusion
applications and for ReZorce(®) mono-material recyclable barrier packaging.

 

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites
in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam
products manufacture and conversion), Massachusetts, USA, Stilling, Denmark
(microcellular foam technology) and Jiangsu Province, China (T-FIT).

www.zotefoams.com (http://www.zotefoams.com)

 

AZOTE(®), ZOTEK(®), ReZorce(®) and T-FIT(®) are registered trademarks of
Zotefoams plc.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAIFMFTMTATBBJ